Biotechnology - Raleigh, North Carolina, United States
AccuBeing has developed an integrated platform to provide patients with comprehensive cancer treatment specific to each individual's cancer. Through AccuBeing or AccuBeing's partners, patients will be enrolled in revolutionary personalized clinical trials developed based on extensive genetic and molecular analysis and personalized cancer modeling. Drug screens of cancer treatments not yet commercially available are designed utilizing cutting-edge artificial intelligence machine learning algorithms which supplement the experience of our cancer-treatment experts. These combined technologies allow for the rapid identification of treatments specifically customized to an individual cancer. By combining these technologies into one service, AccuBeing provides a powerful platform to unite patients throughout the world, with clinical trials designed for their cancer.
Outlook
Nginx
WordPress.org
Google Apps
Amazon AWS